Intellia Therapeutics (NTLA) EBITDA (2015 - 2026)
Intellia Therapeutics (NTLA) recorded EBITDA of -$110.66 million in Q2 2026, compared with -$107.5 million a year earlier.
Powered by 
Analysis
Intellia Therapeutics (NTLA) EBITDA (2015 - 2026) Analysis & Trends
On a TTM basis, Intellia Therapeutics' EBITDA came in at -$414.38 million as of Jun 30, 2026; for FY2025, it was -$431.19 million.
- Across earlier years, EBITDA came in at -$523.96 million in FY2024, -$506.29 million in FY2023, -$450.56 million in FY2022 and -$260.95 million in FY2021.
- The Q2 2026 figure is the lowest quarterly EBITDA since Q1 2025.
- Per Business Quant, the preceding three quarters came in at -$98.33 million (Q1 2026), -$96.31 million (Q4 2025) and -$109.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.17 Bn | 1,135.76 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 633.70 Bn | 552.23 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.94 Bn | 477.06 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 378.10 Bn | 332.47 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 303.72 Bn | 267.71 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 266.46 Bn | 240.15 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.07 Bn | 196.47 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.22 Bn | 168.41 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 172.39 Bn | 119.04 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Intellia Therapeutics | 1.56 Bn | -216.29 Mn | - | -110.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -110.66 Mn |
| Mar 31, 2026 | -98.33 Mn |
| Dec 31, 2025 | -96.31 Mn |
| Sep 30, 2025 | -109.08 Mn |
| Jun 30, 2025 | -107.50 Mn |
| Mar 31, 2025 | -118.31 Mn |
| Dec 31, 2024 | -133.87 Mn |
| Sep 30, 2024 | -142.17 Mn |
| Jun 30, 2024 | -136.44 Mn |
| Mar 31, 2024 | -111.49 Mn |
| Dec 31, 2023 | -137.40 Mn |
| Sep 30, 2023 | -128.82 Mn |
| Jun 30, 2023 | -130.16 Mn |
| Mar 31, 2023 | -109.91 Mn |
| Dec 31, 2022 | -108.03 Mn |
| Sep 30, 2022 | -103.58 Mn |
| Jun 30, 2022 | -96.46 Mn |
| Mar 31, 2022 | -142.49 Mn |
| Dec 31, 2021 | -78.53 Mn |
| Sep 30, 2021 | -70.21 Mn |
API Access
Intellia Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();